Published in Clin Exp Immunol on November 01, 2013
Dynamics of lung defense in pneumonia: resistance, resilience, and remodeling. Annu Rev Physiol (2014) 0.89
Macrophage immunoregulatory pathways in tuberculosis. Semin Immunol (2014) 0.88
miR-15a/16 regulates macrophage phagocytosis after bacterial infection. J Immunol (2014) 0.84
Key mechanisms governing resolution of lung inflammation. Semin Immunopathol (2016) 0.81
Inability to sustain intraphagolysosomal killing of Staphylococcus aureus predisposes to bacterial persistence in macrophages. Cell Microbiol (2015) 0.81
Glucocorticoid-Augmented Efferocytosis Inhibits Pulmonary Pneumococcal Clearance in Mice by Reducing Alveolar Macrophage Bactericidal Function. J Immunol (2015) 0.79
Chronic Household Air Pollution Exposure Is Associated with Impaired Alveolar Macrophage Function in Malawian Non-Smokers. PLoS One (2015) 0.76
Proteasome β5i Subunit Deficiency Affects Opsonin Synthesis and Aggravates Pneumococcal Pneumonia. PLoS One (2016) 0.76
The therapeutic potential of epigenetic manipulation during infectious diseases. Pharmacol Ther (2016) 0.75
Lung epithelium and myeloid cells cooperate to clear acute pneumococcal infection. Mucosal Immunol (2015) 0.75
Polyamine transporter in Streptococcus pneumoniae is essential for evading early innate immune responses in pneumococcal pneumonia. Sci Rep (2016) 0.75
Induction of Pulmonary Granuloma Formation by Propionibacterium acnes Is Regulated by MyD88 and Nox2. Am J Respir Cell Mol Biol (2017) 0.75
Mycobacterium tuberculosis exploits the PPM1A signaling pathway to block host macrophage apoptosis. Sci Rep (2017) 0.75
Role of Streptococcus pneumoniae Proteins in Evasion of Complement-Mediated Immunity. Front Microbiol (2017) 0.75
The RNA uridyltransferase Zcchc6 is expressed in macrophages and impacts innate immune responses. PLoS One (2017) 0.75
THP-1-derived macrophages render lung epithelial cells hypo-responsive to Legionella pneumophila - a systems biology study. Sci Rep (2017) 0.75
Alternative activation of macrophages. Nat Rev Immunol (2003) 27.53
Exploring the full spectrum of macrophage activation. Nat Rev Immunol (2008) 26.08
THE DIFFERENTIATION OF MONONUCLEAR PHAGOCYTES. MORPHOLOGY, CYTOCHEMISTRY, AND BIOCHEMISTRY. J Exp Med (1965) 21.86
Nitric oxide and macrophage function. Annu Rev Immunol (1997) 12.77
Endocytosis and the recycling of plasma membrane. J Cell Biol (1983) 10.24
Mechanisms of phagocytosis in macrophages. Annu Rev Immunol (1999) 9.66
Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol (2009) 8.67
Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation. Science (2011) 8.53
Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood (1998) 5.02
The in vitro differentiation of mononuclear phagocytes. V. The formation of macrophage lysosomes. J Exp Med (1966) 4.84
TLR signalling augments macrophage bactericidal activity through mitochondrial ROS. Nature (2011) 4.16
Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteria. Nat Immunol (2011) 3.48
Alveolar macrophages have a protective antiinflammatory role during murine pneumococcal pneumonia. Am J Respir Crit Care Med (2002) 3.27
Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages. J Immunol (2000) 3.19
Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. J Clin Invest (2009) 3.16
Distinct differentiation potential of blood monocyte subsets in the lung. J Immunol (2007) 3.16
Inhibitory and bactericidal effects of hydrogen peroxide production by Streptococcus pneumoniae on other inhabitants of the upper respiratory tract. Infect Immun (2000) 2.91
Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis. Infect Immun (1997) 2.85
Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion. J Exp Med (2003) 2.56
Lung macrophages serve as obligatory intermediate between blood monocytes and alveolar macrophages. J Immunol (2007) 2.55
The human alveolar macrophage: isolation, cultivation in vitro, and studies of morphologic and functional characteristics. J Clin Invest (1971) 2.47
Pneumolysin activates the NLRP3 inflammasome and promotes proinflammatory cytokines independently of TLR4. PLoS Pathog (2010) 2.33
Innate and cytokine-driven signals, rather than microbial antigens, dominate in natural killer T cell activation during microbial infection. J Exp Med (2011) 2.30
Direct evidence for a bone marrow origin of the alveolar macrophage in man. Science (1976) 2.23
Factors contributing to hydrogen peroxide resistance in Streptococcus pneumoniae include pyruvate oxidase (SpxB) and avoidance of the toxic effects of the fenton reaction. J Bacteriol (2003) 2.20
The prolonged life-span of alveolar macrophages. Am J Respir Cell Mol Biol (2008) 2.16
Constitutively activated Akt-1 is vital for the survival of human monocyte-differentiated macrophages. Role of Mcl-1, independent of nuclear factor (NF)-kappaB, Bad, or caspase activation. J Exp Med (2001) 2.06
Burden of community-acquired pneumonia in North American adults. Postgrad Med (2010) 1.96
The acute respiratory distress syndrome. Ann Intern Med (2004) 1.96
FLICE-inhibitory protein expression during macrophage differentiation confers resistance to fas-mediated apoptosis. J Exp Med (1999) 1.92
Alveolar macrophage apoptosis contributes to pneumococcal clearance in a resolving model of pulmonary infection. J Immunol (2003) 1.88
The apoptotic response to pneumolysin is Toll-like receptor 4 dependent and protects against pneumococcal disease. Infect Immun (2005) 1.86
Global transcriptional analysis of clpP mutations of type 2 Streptococcus pneumoniae and their effects on physiology and virulence. J Bacteriol (2002) 1.71
Role of manganese-containing superoxide dismutase in oxidative stress and virulence of Streptococcus pneumoniae. Infect Immun (2000) 1.69
Innate immunity in the lungs. Proc Am Thorac Soc (2005) 1.66
Macrophage-dependent apoptosis of CD4+ T lymphocytes from HIV-infected individuals is mediated by FasL and tumor necrosis factor. J Exp Med (1997) 1.63
Pneumolysin, a protein toxin of Streptococcus pneumoniae, induces nitric oxide production from macrophages. Infect Immun (1999) 1.60
The NLRP3 inflammasome is differentially activated by pneumolysin variants and contributes to host defense in pneumococcal pneumonia. J Immunol (2011) 1.54
Virulence of Streptococcus pneumoniae: PsaA mutants are hypersensitive to oxidative stress. Infect Immun (2002) 1.52
Human neutrophils kill Streptococcus pneumoniae via serine proteases. J Immunol (2009) 1.49
Molecular analysis of the psa permease complex of Streptococcus pneumoniae. Mol Microbiol (2004) 1.46
Dynamic changes in Mcl-1 expression regulate macrophage viability or commitment to apoptosis during bacterial clearance. J Clin Invest (2005) 1.42
Phagocytosis of Staphylococcus aureus by macrophages exerts cytoprotective effects manifested by the upregulation of antiapoptotic factors. PLoS One (2009) 1.41
Role of HtrA in the virulence and competence of Streptococcus pneumoniae. Infect Immun (2004) 1.40
Phagocytosis and phagosome acidification are required for pathogen processing and MyD88-dependent responses to Staphylococcus aureus. J Immunol (2010) 1.38
Immune-mediated phagocytosis and killing of Streptococcus pneumoniae are associated with direct and bystander macrophage apoptosis. J Infect Dis (2001) 1.35
Critical roles of ASC inflammasomes in caspase-1 activation and host innate resistance to Streptococcus pneumoniae infection. J Immunol (2011) 1.33
Reactive oxygen species regulate neutrophil recruitment and survival in pneumococcal pneumonia. Am J Respir Crit Care Med (2008) 1.33
Nitric oxide levels regulate macrophage commitment to apoptosis or necrosis during pneumococcal infection. FASEB J (2004) 1.33
Resident macrophage proliferation in mice depleted of blood monocytes by strontium-89. Lab Invest (1982) 1.31
Macrophages require constitutive NF-kappaB activation to maintain A1 expression and mitochondrial homeostasis. Mol Cell Biol (2000) 1.30
Distinct macrophage subpopulations characterize acute infection and chronic inflammatory lung disease. J Immunol (2012) 1.28
Streptococcus pneumoniae-associated human macrophage apoptosis after bacterial internalization via complement and Fcgamma receptors correlates with intracellular bacterial load. J Infect Dis (2003) 1.28
Decreased alveolar macrophage apoptosis is associated with increased pulmonary inflammation in a murine model of pneumococcal pneumonia. J Immunol (2006) 1.27
Chitinase 3-like-1 promotes Streptococcus pneumoniae killing and augments host tolerance to lung antibacterial responses. Cell Host Microbe (2012) 1.23
CD8+ cells enhance resistance to pulmonary serotype 3 Streptococcus pneumoniae infection in mice. J Immunol (2010) 1.17
Apoptotic cell death in the pathogenesis of infectious diseases. J Infect (2001) 1.14
Characterization of the Streptococcus pneumoniae NADH oxidase that is required for infection. Microbiology (2001) 1.13
Interleukin-1β regulates CXCL8 release and influences disease outcome in response to Streptococcus pneumoniae, defining intercellular cooperation between pulmonary epithelial cells and macrophages. Infect Immun (2011) 1.11
A pneumococcal MerR-like regulator and S-nitrosoglutathione reductase are required for systemic virulence. J Infect Dis (2007) 1.08
TNF-related apoptosis-inducing ligand (TRAIL) exerts therapeutic efficacy for the treatment of pneumococcal pneumonia in mice. J Exp Med (2012) 1.08
Bactericidal mechanisms in rabbit alveolar macrophages: evidence against peroxidase and hydrogen peroxide bactericidal mechanisms. Infect Immun (1976) 1.06
Phagosomal degradation increases TLR access to bacterial ligands and enhances macrophage sensitivity to bacteria. J Immunol (2011) 1.05
Inhibition of macrophage apoptosis by Neisseria meningitidis requires nitric oxide detoxification mechanisms. Infect Immun (2006) 1.04
Distinct roles for extracellular-signal-regulated protein kinase (ERK) mitogen-activated protein kinases and phosphatidylinositol 3-kinase in the regulation of Mcl-1 synthesis. Biochem J (2001) 1.04
Proteome comparison of alveolar macrophages with monocytes reveals distinct protein characteristics. Am J Respir Cell Mol Biol (2004) 1.03
A cardinal role for cathepsin d in co-ordinating the host-mediated apoptosis of macrophages and killing of pneumococci. PLoS Pathog (2011) 1.02
The pneumococcal response to oxidative stress includes a role for Rgg. Microbiology (2009) 1.02
Distinct cell death programs in monocytes regulate innate responses following challenge with common causes of invasive bacterial disease. J Immunol (2010) 1.01
Interplay of pneumococcal hydrogen peroxide and host-derived nitric oxide. Infect Immun (2006) 1.00
Concerted action of lactate oxidase and pyruvate oxidase in aerobic growth of Streptococcus pneumoniae: role of lactate as an energy source. J Bacteriol (2008) 0.98
Pneumococcal pneumonia: mechanisms of infection and resolution. Chest (2012) 0.97
Pneumococci stimulate the production of the inducible nitric oxide synthase and nitric oxide by murine macrophages. J Infect Dis (1998) 0.96
Human monocytes promote Th1 and Th17 responses to Streptococcus pneumoniae. Infect Immun (2011) 0.96
A serotype 3 pneumococcal capsular polysaccharide-specific monoclonal antibody requires Fcγ receptor III and macrophages to mediate protection against pneumococcal pneumonia in mice. Infect Immun (2012) 0.94
M2 macrophage polarisation is associated with alveolar formation during postnatal lung development. Respir Res (2013) 0.93
Human macrophage development: a morphometric study. J Anat (1987) 0.93
Pneumococcal gene complex involved in resistance to extracellular oxidative stress. Infect Immun (2012) 0.92
Nitric oxide exerts distinct effects in local and systemic infections with Streptococcus pneumoniae. Microb Pathog (2004) 0.92
Expression of inducible nitric oxide synthase and formation of nitric oxide by alveolar macrophages: an interspecies comparison. Environ Health Perspect (1997) 0.91
The protein tyrosine kinase Tec regulates a CD44highCD62L- Th17 subset. J Immunol (2010) 0.90
The lack of Pneumococcal surface protein C (PspC) increases the susceptibility of Streptococcus pneumoniae to the killing by microglia. Med Microbiol Immunol (2005) 0.88
Monocytes regulate the mechanism of T-cell death by inducing Fas-mediated apoptosis during bacterial infection. PLoS Pathog (2012) 0.88
Flow-cytometric and ultrastructural analysis of alveolar macrophage maturation. J Leukoc Biol (1986) 0.88
Contrasting roles for reactive oxygen species and nitric oxide in the innate response to pulmonary infection with Streptococcus pneumoniae. Vaccine (2006) 0.86
The MerR/NmlR family transcription factor of Streptococcus pneumoniae responds to carbonyl stress and modulates hydrogen peroxide production. J Bacteriol (2010) 0.85
Proteomic evaluation and validation of cathepsin D regulated proteins in macrophages exposed to Streptococcus pneumoniae. Mol Cell Proteomics (2011) 0.84
An operon in Streptococcus pneumoniae containing a putative alkylhydroperoxidase D homologue contributes to virulence and the response to oxidative stress. Microb Pathog (2006) 0.83
Proteases of macrophages in rat peritoneal exudate, with special reference to the effects of actinomycete protease inhibitors. Biochim Biophys Acta (1972) 0.82
Deficiency of tumour necrosis factor-related apoptosis-inducing ligand exacerbates lung injury and fibrosis. Thorax (2012) 0.80
Virulence attenuation of Streptococcus pneumoniae clpP mutant by sensitivity to oxidative stress in macrophages via an NO-mediated pathway. J Microbiol (2010) 0.80
A decoy receptor 3 analogue reduces localised defects in phagocyte function in pneumococcal pneumonia. Thorax (2012) 0.76
Terminal restriction fragment length polymorphism analysis program, a web-based research tool for microbial community analysis. Appl Environ Microbiol (2000) 5.54
Immune function, mutant frequency, and cancer risk in the DNA repair defective genodermatoses xeroderma pigmentosum, Cockayne's syndrome, and trichothiodystrophy. J Invest Dermatol (1990) 2.31
Exclusive elemental diet impacts on the gastrointestinal microbiota and improves symptoms in patients with chronic pouchitis. J Crohns Colitis (2012) 2.00
Molecular analysis of ouabain-resistant mutants of the mouse lymphoma cell line L5178Y. Mutagenesis (1987) 2.00
The biogenesis of c-type cytochromes in Escherichia coli requires a membrane-bound protein, DipZ, with a protein disulphide isomerase-like domain. Mol Microbiol (1995) 1.84
Mutations which alter splicing in the human hypoxanthine-guanine phosphoribosyltransferase gene. Nucleic Acids Res (1992) 1.83
Nucleotide sequence, organisation and structural analysis of the products of genes in the nirB-cysG region of the Escherichia coli K-12 chromosome. Eur J Biochem (1990) 1.66
Clinical heterogeneity within xeroderma pigmentosum associated with mutations in the DNA repair and transcription gene ERCC3. Am J Hum Genet (1994) 1.64
Systematic review: the effect of prunes on gastrointestinal function. Aliment Pharmacol Ther (2014) 1.62
Organization of kappa light chain genes in germ-line and somatic tissue. Proc Natl Acad Sci U S A (1980) 1.61
Possible association between mutant frequency in peripheral lymphocytes and domestic radon concentrations. Lancet (1991) 1.59
The calculation of target height reconsidered. Horm Res (2003) 1.56
Organizing pneumonia. Features and prognosis of cryptogenic, secondary, and focal variants. Arch Intern Med (1997) 1.55
Escherichia coli K-12 genes essential for the synthesis of c-type cytochromes and a third nitrate reductase located in the periplasm. Mol Microbiol (1996) 1.52
Molecular cloning and functional analysis of the cysG and nirB genes of Escherichia coli K12, two closely-linked genes required for NADH-dependent nitrite reductase activity. Mol Gen Genet (1985) 1.46
Circulating nitrite anions are a directly acting vasodilator and are donors for nitric oxide. Clin Sci (Lond) (2002) 1.45
Molecular and cellular analysis of the DNA repair defect in a patient in xeroderma pigmentosum complementation group D who has the clinical features of xeroderma pigmentosum and Cockayne syndrome. Am J Hum Genet (1995) 1.44
A seven-gene operon essential for formate-dependent nitrite reduction to ammonia by enteric bacteria. Mol Microbiol (1994) 1.42
A global paleoclimate observing system. Science (2001) 1.38
In vivo analysis of Fas/FasL interactions in HIV-infected patients. J Clin Invest (1998) 1.36
The nature and origin of mutations which block a temporal sequence for genic expression in paramecium. Genetics (1967) 1.32
Nitrate reduction in the periplasm of gram-negative bacteria. Adv Microb Physiol (2001) 1.28
The role of proprioception and attention in a visuomotor adaptation task. Exp Brain Res (2000) 1.28
Clinical experience with trisomies 18 and 13. J Med Genet (1978) 1.27
ProbeDesigner: for the design of probesets for branched DNA (bDNA) signal amplification assays. Bioinformatics (1999) 1.23
Genetic family history questionnaire. J Med Genet (1978) 1.21
Mitochondrial transport proteins of the brain. J Neurosci Res (2007) 1.19
The Escherichia coli cysG promoter belongs to the 'extended -10' class of bacterial promoters. Biochem J (1993) 1.18
Effect of a developmental program on motor performance in infants born preterm. Aust J Physiother (2001) 1.17
Regulation and sequence of the structural gene for cytochrome c552 from Escherichia coli: not a hexahaem but a 50 kDa tetrahaem nitrite reductase. Mol Microbiol (1993) 1.17
An essential role for DsbA in cytochrome c synthesis and formate-dependent nitrite reduction by Escherichia coli K-12. Arch Microbiol (1995) 1.13
The Escherichia coli CcmG protein fulfils a specific role in cytochrome c assembly. Biochem J (2001) 1.13
Peer-based differences among boys with ADHD. J Clin Child Psychol (2000) 1.11
Reporter genes and fluorescent probes for studying the colonisation of biofilms in a drinking water supply line by enteric bacteria. FEMS Microbiol Lett (1995) 1.04
Identification of the formate dehydrogenases and genetic determinants of formate-dependent nitrite reduction by Escherichia coli K12. J Gen Microbiol (1993) 1.02
Rates of, and the factors affecting, cycle helmet use among secondary schoolchildren in East Sussex and Kent. Inj Prev (1998) 1.00
CD4 regulates susceptibility to Fas ligand- and tumor necrosis factor-mediated apoptosis. J Exp Med (1998) 0.99
A comparison of the response of unstimulated and stimulated T-lymphocytes and fibroblasts from normal, xeroderma pigmentosum and trichothiodystrophy donors to the lethal action of UV-C. Mutat Res (1992) 0.99
The role of the genes nrf EFG and ccmFH in cytochrome c biosynthesis in Escherichia coli. Mol Gen Genet (1996) 0.98
Detection of somatic mutations in man: evaluation of the microtitre cloning assay for T-lymphocytes. Mutagenesis (1986) 0.97
The fluctuation test as a more sensitive system for determining induced mutation in L5178Y mouse lymphoma cells. Mutat Res (1976) 0.96
The prevalence of ay and ad subtypes of the hepatitis B surface antigen in Belgium. Infection (1978) 0.96
Social defeat increases alcohol preference of C57BL/10 strain mice; effect prevented by a CCKB antagonist. Psychopharmacology (Berl) (2005) 0.95
A new approach to probability of survival scoring for trauma quality assurance. J Trauma (1993) 0.94
Circulating catecholamine concentrations in cocaine-exposed neonates: a pilot study. Pediatrics (1991) 0.94
Transcriptional control of the cysG gene of Escherichia coli K-12 during aerobic and anaerobic growth. Eur J Biochem (1990) 0.94
Mycophenolate mofetil increases cytomegalovirus invasive organ disease in renal transplant patients. Clin Transplant (2000) 0.93
Urban firearm deaths: a five-year perspective. J Trauma (1993) 0.93
Long-term survival and preservation of natural killer cell activity in a xeroderma pigmentosum patient with spontaneous regression and multiple deposits of malignant melanoma. Br J Dermatol (1991) 0.93
Short-term tests for transplacentally active carcinogens. I. Micronucleus formation in fetal and maternal mouse erythroblasts. Mutat Res (1981) 0.93
Self-moved target eye tracking in control and deafferented subjects: roles of arm motor command and proprioception in arm-eye coordination. J Neurophysiol (1996) 0.92
Evidence for stronger visuo-motor than visuo-proprioceptive conflict during mirror drawing performed by a deafferented subject and control subjects. Exp Brain Res (2006) 0.92
Antisense mapping of MOR-1 in rats: distinguishing between morphine and morphine-6beta-glucuronide antinociception. J Pharmacol Exp Ther (1997) 0.92
The cost of treatment failure: resource use and costs incurred by hepatitis C virus genotype 1-infected patients who do or do not achieve sustained virological response to therapy. J Viral Hepat (2013) 0.92
Abnormal erythemal response and elevated T lymphocyte HRPT mutant frequency in Cockayne's syndrome. Br J Dermatol (1991) 0.92
Granular materials: packing grains by thermal cycling. Nature (2006) 0.92
Weight judgment. The discrimination capacity of a deafferented subject. Brain (1995) 0.90
Low alcohol preference among the "high alcohol preference" C57 strain of mice; preference increased by saline injections. Psychopharmacology (Berl) (1999) 0.90
Genotoxic effects of radiotherapy and chemotherapy on the circulating lymphocytes of breast cancer patients. III: Measurement of mutant frequency to 6-thioguanine resistance. Mutagenesis (1990) 0.90
Apoptosis in HIV-1 infection. J Eur Acad Dermatol Venereol (2003) 0.90
CT-determined intracranial volume for a normal population. J Craniofac Surg (2000) 0.89
HLA antigens and homogeneous immunoglobulins. Clin Immunol Immunopathol (1977) 0.89
Human beta-herpesvirus interactions in solid organ transplant recipients. J Infect Dis (2000) 0.89
Improved outcomes associated with advances in therapy for invasive fungal infections in immunocompromised hosts. J Infect (2007) 0.89
Monocyte and macrophage dysfunction as a cause of HIV-1 induced dysfunction of innate immunity. Curr Mol Med (2010) 0.89
UV-C sensitivity of unstimulated and stimulated human lymphocytes from normal and xeroderma pigmentosum donors in the comet assay: a potential diagnostic technique. Mutat Res (1992) 0.89
Does the oculo-manual co-ordination control system use an internal model of the arm dynamics? Neurosci Lett (1999) 0.88
Immune responsiveness in a rat model for type II diabetes (Zucker rat, fa/fa): susceptibility to Candida albicans infection and leucocyte function. J Med Microbiol (1996) 0.88
Assignment of the g = 4.1 EPR signal to manganese in the S2 state of the photosynthetic oxygen-evolving complex: an X-ray absorption edge spectroscopy study. Biochim Biophys Acta (1987) 0.88
Control of single-joint movements in deafferented patients: evidence for amplitude coding rather than position control. Exp Brain Res (1996) 0.88
Problems of disability and rehabilitation in patients with chronic skin diseases. Arch Dermatol (1972) 0.88
Hand-mouth coordination, congenital absence of limb, and evidence for innate body schemas. Brain Cogn (1998) 0.87
Sumatriptan in chronic cluster headache: results of continuous treatment for eleven months. Cephalalgia (1992) 0.87
Isolation and molecular characterization of spontaneous mutants of lymphoblastoid cells with extended loss of heterozygosity. Mutat Res (1997) 0.87
Beagle puppy model of perinatal cerebral infarction. Acute changes in cerebral blood flow and metabolism during hemorrhagic hypotension. J Neurosurg (1985) 0.87
Proprioception in motor learning: lessons from a deafferented subject. Exp Brain Res (2015) 0.87
Maternal and fetal serum 1,25-dihydroxyvitamin D levels at term. J Pediatr (1980) 0.87
Clozapine-associated priapism: a case report. J Urol (1992) 0.87
Variability of presentation in hereditary neuropathy with liability to pressure palsy results in underrecognition. Ann N Y Acad Sci (1999) 0.87
A phase I-II trial of topotecan and gemcitabine in patients with previously treated, advanced non-small cell lung cancer (LOA-3). Cancer Invest (2001) 0.86
Invasive pneumococcal disease and the potential for prevention by vaccination in the United Kingdom. J Infect (2006) 0.86
Polyol-combinant saliva stimulants and oral health in Veterans Affairs patients--an exploratory study. Spec Care Dentist (1997) 0.86
Facial expression recognition by people with mobius syndrome. Cogn Neuropsychol (2000) 0.86
Analysis of TYA protein regions necessary for formation of the Ty1 virus-like particle structure. Virology (1995) 0.86
A breathless triathlete. Lancet (2002) 0.86
Effect of diet and vitamin C on DNA strand breakage in freshly-isolated human white blood cells. Mutat Res (1994) 0.86
Psychopharmacological screening criteria development project. JAMA (1979) 0.86
An antigenic subunit present in rotavirus infected faeces. J Gen Virol (1977) 0.86
Characterisation of Escherichia coli K-12 mutants defective in formate-dependent nitrite reduction: essential roles for hemN and the menFDBCE operon. Arch Microbiol (1997) 0.86
Reversible and irreversible effects of alkaline pH on Photosystem II electron-transfer reactions. Biochim Biophys Acta (1986) 0.85
Local anaesthesia for major general surgical procedures. A review of 116 cases over 12 years. Postgrad Med J (1996) 0.84
Acute coronary occlusion and in-stent thrombosis in a patient with essential thrombocythemia. Cathet Cardiovasc Diagn (1998) 0.84
Ethyl methanesulphonate mutagenesis with L5178Y mouse lymphoma cells: a comparison of ouabain, thioguanine and excess thymidine resistance. Mutat Res (1976) 0.84
Extended-term cultures of human T-lymphocytes: a practical alternative to primary human lymphocytes for use in genotoxicity testing. Mutagenesis (1995) 0.84
Suggestions concerning the relationship between mutant frequency and mutation rate at the hprt locus in human peripheral T-lymphocytes. Mutat Res (1995) 0.84
Preemptive oral treatment with sumatriptan during a cluster period. Headache (1996) 0.84
Catabolite regulation of two Escherichia coli operons encoding nitrite reductases: role of the Cra protein. Arch Microbiol (1997) 0.83
A serum-sensitive, sialyltransferase-deficient mutant of Neisseria gonorrhoeae defective in conversion to serum resistance by CMP-NANA or blood cell extracts. Microb Pathog (1995) 0.83
Upper and lower airway nitric oxide levels in primary ciliary dyskinesia, cystic fibrosis and asthma. Respir Med (2013) 0.83